NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/24/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/24/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/24/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/21/26 | 8-K | Current report |
|
  |
6 |
| 04/06/26 | SCHEDULE 13G/A | Statement of Beneficial Ownership by Certain Investors |
|
4 | |
| 03/26/26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] |
|
|
110 |
| 03/25/26 | 8-K | Current report |
|
|
11 |
| 01/23/26 | 424B3 | Prospectus [Rule 424(b)(3)] |
|
19 | |
| 01/23/26 | 424B3 | Prospectus [Rule 424(b)(3)] |
|
25 | |
| 01/21/26 | EFFECT | Notice of Effectiveness |
|
1 |